In agreement with other reports showing that low-dose IL-2 treatment protects NOD mice from diabetes development, insulitis was significantly reduced in the IL-2c treated mice (p < 0.001, Fig. 6a). This evidence concerns the gene IL2 and diabetes mellitus.